Search…

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    newshunt
    newshunt

    Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman

    6 days ago

    Sun Pharma's India business head, Kirti Ganorkar, will become the managing director on September 1, succeeding founder Dilip Shanghvi. Shanghvi will transition to executive chairman, while his son Aalok will oversee North America as COO. Richard Ascroft will take over as CEO of North America, replacing Abhay Gandhi, as Sun Pharma continues its strategic leadership evolution.
    Click here to Read more
    Prev Article
    Gensol group faces insolvency over Ireda dues
    Next Article
    Israel-Iran tensions: India has adequate energy supplies, says Union minister Puri amid rising crude prices; citing energy strategy trilemma

    Related Business Updates:

    Comments (0)

      Leave a Comment